CONGRESS|#EHA2021| Marc S Raab, discussed the impact of cell based immunotherapy on pretreated refractory MM pt. Role of cytokine release syndrome and immune effector cell associated neurologic syndrome was also discussed #mmsm, #myeloma, @UniHeidelberg pic.twitter.com/45vbwJ95t1
— Multiple Myeloma Hub (@MM_Hub) June 12, 2021